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A B S T R A C T
The poor dissolution characteristics of water-insoluble drugs are a major challenge for phar-
maceutical scientists. Reduction of the particle size/increase in the surface area of the drug
is a widely used and relatively simple method for increasing dissolution rates. The objec-
tive of this study was to improve solubility, release and comparability of dissolution of a
poorly soluble drug using two different types of formulations (solid dispersions and
microspheres). Hydrochlorothiazide was used as a model drug. The solid dispersions and
microspheres were prepared by solvent evaporation method using ethyl cellulose,
hydroxypropyl methylcellulose in different drug-to-carrier ratios (1:1, 1:2 w:w). The pre-
pared formulations were evaluated for interaction study by Fourier transform infrared
spectroscopy, differential scanning calorimetry, percentage of practical yield, drug loading,
surface morphology by scanning electron microscopy, optical microscopy and in-vitro release
studies. The results showed no interaction between the drug and polymer, amorphous state
of solid dispersions and microspheres, percentage yield of 42.53% to 78.10%, drug content
of 99.60 % to 99.64%, good spherical appearance in formulation VI and significant increase
in the dissolution rate.
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1. Introduction
Among all newly discovered chemical entities about 40% of
drugs are lipophilic and fail to reach the market due to their
poor aqueous solubility [1]. For orally administered drugs solu-
bility is one of the rate limiting parameters to achieve their
desired concentration in the systemic circulation in pharma-
cological response [2]. According to the equation of Noyes and
Whitney, this may be achieved by reduction of the particle size/
increase in the surface area of the drug which is accessible for
the dissolution medium and an enhancement of its solubil-
ity in addition to a relatively simple method for increasing
dissolution rates [3]. However, altering the drug particle itself
carries obvious limitations which are inadequate for enhance-
ment of bioavailability. Therefore, additional physical changes,
including control of drug release from their formulations should
be taken into consideration [4]. Moreover, there are two key
strategies to alter the release and subsequent absorption of
drugs: one is based on a modification of the drug, and the other
is based on a modification of the dosage form as a new drug
delivery system [5].
The new drug delivery systems are having an edge over
conventional ones in terms of many biopharmaceutical pa-
rameters; among such drug delivery systems are controlled/
prolonged release solid dispersion [6,7] and micro particles/
microsphere [8,9]. These systems can achieve therapeutically
effective concentration of the drug in the systemic circula-
tion over an extended period of time with better patient
compliance [10,11]. Water insoluble carriers are generally used
to produce a controlled release formulation. The properties
of the carriers have major influences on the release profile of
the dispersed drug, specifically the second generation carri-
ers. These carriers include ethyl cellulose, hydroxypropyl
cellulose, hydroxypropyl methylcellulose, cellulose acetate
phthalate, ethyl acetate, Chitosan, and methacrylic acid co-
polymers [12].
In order to investigate the effect of second generation
polymers on the dissolution release mechanism of poorly
soluble drugs from solid dispersions (SD) and microspheres
(MS), hydrochlorothiazide [(6-chloro-1,1-dioxo-3,4-dihydro-2H-
1,2,4-benzothiadiazine-7 sulfonamide) (HCT), a poorly water
soluble drug (0.7 mg/ml)] was used as a model drug for
these purposes. The HCT is a potent diuretic which inhibits
the kidney’s ability to retain water. It is widely used in the
management of hypertension in combination with cardiovas-
cular drugs. It is a white or nearly white, almost odorless,
crystalline powder and has a slightly bitter taste. Hydrochlo-
rothiazide is considered as a class IV drug according to the
BCS. It has low and variable oral bioavailability which is at-
tributed to poor solubility, slow dissolution and poor membrane
permeability [13]. Hydrochlorothiazide is absorbed from the
GI tract and apparently not metabolized and excreted un-
changed in urine. At least 61% of the drug is reportedly
eliminated from the body when excretion is essentially
completed within 24 h post administration. The oral
bioavailability of the drug was reported to be 60–80% of the
administered dose [14]. In this study, two different types of
formulations such as solid dispersions and microspheres were
prepared by solvent evaporation method using ethyl cellu-
lose (EC) and hydroxylpropyl methylcellulose (HPMC) in
different drug-to-carrier ratios (1:1, 1:2 w:w). These prepara-
tions may release the maximum amount of the drug for
controlling/prolonged period of time and it may also in-
crease the residence time; this in turn may increase the
bioavailability when compared to conventional drug multiple
dosing regimen.
2. Materials and methods
2.1. Materials
Hydrochlorothiazide was obtained from IPCA Laboratories
Ltd. (Mumbai, India). Hyroxypropyl methylcellulose was
purchased from Colorcon, Mumbai. Ethylcellulose and
Poly vinyl alcohol (PVA) were procured from Sigma-Aldrich,
Germany. All other chemicals were of analytical reagent
grade.
2.2. Preparations of solid dispersions by solvent
evaporation method
The physical mixture of the drug and water soluble carrier were
dissolved in 20 ml of common solvent (5% acetic acid for FI,
FII and Acetone for FIII, FIV) and the resulting clear solution
is rapidly heated for evaporating the solvent and to get a glassy
solid mass. The obtained solid mass was transferred onto alu-
minum plates and the solvent was left to evaporate in open
air for 2 days. After complete removal of the solvent the solid
dispersions were granulated and stored at 25 °C in desicca-
tors [11,15].
2.3. Preparations of microspheres by emulsion solvent
evaporation method
In this technique the drug is dissolved in a polymer which was
previously dissolved in 50 ml of solvent and the resulting so-
lution is added to aqueous phase containing 5 ml of 1% PVA
as stabilizing agent.The above mixture was agitated at 500 rpm,
then the drug and polymer (EC & HPMC) were transformed into
fine droplet which solidified into rigid microspheres by solvent
evaporation and then collected by filtration and washed with
de-mineralized water and desiccated at room temperature for
24 h [16].
Different concentrations and ratios of polymers used in the
formulation of solid dispersion and microspheres are men-
tioned in Table 1.
2.4. Analytical method for drug concentration
measurements (UV method)
The ultraviolet spectrophotometric method was selected in the
present study for the estimation of hydrochlorothiazide. The
drug solution [20 µl/ml in 0.1M HCl] was scanned in between
the wavelength of 400–200 nm. The wavelength of 273 nm was
selected and utilized for further quantitative analysis.
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2.5. Standard plot of hydrochlorothiazide in 0.1 M
hydrochloric acid buffer
Weighed quantity of hydrochlorothiazide (25 mg) was dis-
solved and the volume made up to 25 ml with 0.1M HCl buffer
pH 1.2 to give a concentration of 1000 µg/ml. From this stock
solution different volumes were transferred into 10 ml volu-
metric flasks and volume was made up to 10 ml with 0.1M HCl
buffer pH 1.2 to get different concentrations ranging from 1 to
15 µg/ml concentrations. The absorbance was measured at
273 nm against a blank using UV spectrophotometer.
2.6. Percentage practical yield
Percentage practical yield is calculated to determine percent
yield or efficiency of any method, thus it is helpful in the se-
lection of appropriate methods of production. Solid dispersions/
microspheres were collected and weighed to determine practical
yield (PY) from the following equation [17]:
Practical Yield
Mass of Solid dispersions
Microspheres r
%( )
=
ecovered Practical mass
Mass of carrier and drug used
in f
( )
ormulation Theoretical mass( )
× 100 (1)
2.7. FT-infrared spectroscopy
Infrared spectroscopy was conducted using an Avatac 320-FT
IR spectrophotometer and the spectrum was recorded in the
region of 4000–400 cm−1. The procedure consisted of dispers-
ing a sample (drug, solid dispersions and microspheres) in KBR
(200–400 mg) and compressing into the discs by applying a pres-
sure of 5 tons for 5 min in a hydraulic press. The pellet was
placed in the light path and the spectrum was obtained.
2.8. Differential scanning calorimetry
Differential scanning calorimetry (DSC) measurements were
carried out on a Modulated DSC V1.1A TA instrument 2000
(Japan) equipped with a thermal analysis data system (TA in-
strument).The instrument was calibrated using indium (156 °C),
tin (232 °C) and zinc (419.5 °C) as internal standards. Samples
of 2–10 mg were placed in aluminum pans (Al-Crucibles, 40 Al)
and sealed. The probes were heated from 25 to 400 °C at a rate
of 10 K/min under nitrogen atmosphere.
2.9. Drug content
Solid dispersions and microspheres equivalent to 10 mg of hy-
drochlorothiazide were weighed accurately and dissolved in
10 ml of methanol. The solution was filtered, diluted suitably
and drug content was analyzed at 273 nm by UV spectropho-
tometer [18]. The actual drug content was calculated using the
following equation as follows:
Drug content
Amount of Solid dispersions
Microspheres
Th
%( )
=
eoretical amount of Solid dispersions
Microspheres
× 100 (2)
2.10. Scanning electron microscopy
The shape and surface morphology of the microspheres was
examined using Scanning Electron Microscopy (SEM) (JSM–
T20, Tokyo, Japan). An appropriate sample of microspheres was
mounted on metal stubs, using double-sided adhesive tapes.
Samples were gold coated and observed for morphology, at an
acceleration voltage of 15 kV.
2.11. Optical microscopy
The growth of CBZ crystals in water from the various solid dis-
persions was observed using a light microscope (Nikon Inc.,
Melville, NY) and the photos were captured by digital camera
(Sony Electronics Inc., Japan).
2.12. In vitro release study
The dissolution studies on pure drug, tablets and solid
dispersions/microspheres (equivalent to 10 mg of drug) were
performed using dissolution test apparatus. The condition of
dissolution test was as follows: medium – 900 ml 0.1M HCl
(pH 1.2); speed – 100 rpm; temperature – 37 ± 0.5 °C; appara-
tus – USP type II rotating paddle. During the dissolution study,
10 ml aliquot was withdrawn at different time intervals from
5 to 110 min and replaced with an equal volume of fresh
medium. The withdrawn samples were filtered through
Whatman filter paper no. 42 and absorbance was measured
at 273 nm against 0.1M HCl blank.
Table 1 – Composition of formulation and effect of percentage of recovery, drug content.
Formulation (Drug: HCT polymer:
ethyl cellulose
and hydroxy propyl
methyl cellulose)
Drug (g) Polymer (g) PVA
(mg)
Other
ingredient
Solvent evaporation
method
Practical
yield %
Drug
content %
FI D + HPMC-SD (1:1) 1 1 – 5% Acetic acid 61.30 99.63
FII D + HPMC-SD (1:2) 1 2 – 5% Acetic acid 64.15 99.64
FIII D + EC-SD (1:1) 1 1 – Acetone 78.10 99.63
FIV D + EC-SD (1:2) 1 2 – Acetone 62.34 99.60
FV D + HPMC-MS (1:1) 1 1 50 5% Acetic acid 42.53 99.62
FVI D + EC-MS (1:1) 1 1 50 Acetone, PVA 57.79 99.63
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3. Results and discussion
3.1. Standard plot of hydrochlorothiazide in 0.1 M
hydrochloric acid buffer
The Standard plot of HCT was prepared in 0.1 M Hydrochlo-
ric acid buffer, pH 1.2 and the ultraviolet spectrophotometric
method was used to analyze HCT at the wavelength of 273 nm
which revealed good linearity in the solution systems in the
concentration range of 1–15 µg/ml (R2 = 0.9999) (Fig. 1).
3.2. FT-infrared spectroscopy
The FTIR spectrum of pure HCT exhibited presence of char-
acteristic peaks which included peaks at 3356.05 cm−1,
3261.43 cm−1, 3161.75 cm−1 for NH- stretching, peak at
1596.04 cm−1 for stretching of the C=C aromatic ring, peak at
1317.12 cm−1 for C=N stretching, peak at 1239.93 cm−1 for SO2
stretching. The FTIR study did not show any additional peak,
significant shift and disappearance of characteristic peaks in
all the formulations but most of the peaks of drug were present.
This confirms the absence of any physical interaction between
drugs and polymers (Fig. 2). The differences in transmittance
may be due to varying concentration of drug.
3.3. Differential scanning calorimetry
Fig. 3 showed the DSC thermogram of pure drug, polymer
(HPMC, EC) and different dosage form of solid dispersions,
microspheres. The DSC thermogram of HCT exhibited two
thermal events, one at about 270 °C and the second in 340 °C
that could be associated to the HCT melting point and thermal
decomposition, respectively [19]. There was no peak detected
in the HCT dispersed in HPMC and EC solid dispersions (FII,
FIII). These results suggested that the crystallinity of HCT in
solid dispersions disappeared. The lack of a peak in the HCT
encapsulated in HPMC and EC microspheres indicated that the
drug was present in a more amorphous state than in crystal-
line form. From the result it was confirmed that HCT was
crystalline but solid dispersions and microspheres were non-
crystalline and amorphous in the state.
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Fig. 1 – Standard plot for hydrochlorothiazide.
Fig. 2 – FTIR spectra of (a) pure drug – HCT, (b) HPMC, (c) EC, (d) HPMC SD, (e) EC SD, (f) HPMC MS and (g) EC MS.
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3.4. Percentage practical yield and drug content
In all formulations, the drug content was found to be between
99.60% and 99.64% and the practical yield was found to be
between 42.53% and 78.10%. All the formulation of different
ratio showed the presence of high drug content and low prac-
tical yield (Table 1) which indicates that the drug is uniformly
dispersed in the powder and well loaded in the sphere for-
mulation.The high drug content or drug loading is the function
of the characteristics of polymer, drug, surfactant and cross-
linking agent, etc. Since the drug is hydrophobic in nature, there
was less chance of diffusion of drug away from the polymer
network during preparation [20,21]. The product yield de-
pended upon the agglomeration and sticking of polymer to
blades of stirrer and to the wall of the beaker during
microsphere formation. The product yield was also found to
be dependent on the choice of the polymer and its viscosity.
The decrease in yield of the microspheres containing HPMC
polymer than EC polymer may be due to migration of HPMC
into continuous phase forming agglomerates accompanied with
sticking of the polymer to the stirrer blade, beaker surface as
well as during filtration of microspheres [22]. In addition during
evaporation of solvent, the drug may diffuse out of microsphere
together with volatile nature of solvent before the droplet of
microsphere solidification, leading to a low product yield, and
also to either low drug content or low entrapment efficiency
which depends on the choice of the polymer, solvent, drug, pro-
cessing parameter, etc. [23,24],. Therefore, the method solvent
evaporation used in this study appears to be suitable for for-
mulation III when compared to all other formulations.
3.5. Morphological characterization of polymeric
microspheres
Fig. 4a and 4b, showed the morphology of HPMC and EC
microspheres. The surfaces of microparticles depends on (1)
a saturated solution of polymer producing smooth and high
yield microparticles. The undissolved polymer produced ir-
regular and rod shaped particles. (2) The diffusion rate of solvent
is too fast and the solvent may diffuse into the aqueous phase
before stable microparticles are developed and formed, causing
the aggregation of microparticle preparation [25,26]. Among the
two polymers, the HPMC possessed sparing soluble charac-
teristics. There was less chance of formation of smooth and
high yield microspheres using the HPMC polymer, because a
portion of the HPMC polymer solution aggregated in a fiber-
like structure, as it solidified prior to forming microspheres.
Hence, in FV the SEM pictures showed relatively smooth spheri-
cal shaped and fiber-like structure (Fig. 4a). EC possessed good
solubility property in acetone. There was a high chance of for-
mation of smooth and high yield microspheres using the EC
polymer [10]. Due to a saturated solution of polymer and fast
diffusion rate of solvent it showed the smooth spherical shape
and high yield microspheres (Fig. 4b). A similar finding was re-
ported by Dhanalekshmi et al. [8,10]. Due to the solubility and
diffusion rate among the natural polymers, the FVI showed good
spherical appearance.
Fig. 5a–e shows the morphology of pure drug, HPMC and
EC solid dispersion, examined by optical microscopy. The pure
drug appeared in the form of irregular crystal particles whereas
in the case of all the solid dispersion formulations of HCT par-
ticles were in almost amorphous form, which indicates a
reduction in particle size. These observations provide the evi-
dence of solid dispersion formation.
3.6. In-vitro release study
In this study the effect of the release profile of poorly water
soluble drug like HCT from a different dosage form of solid
Fig. 3 – DSC thermogram of pure drug (HCT), polymer
(HPMC, EC) and different dosage form of solid dispersions,
microspheres.
Fig. 4 – Scanning electron microscopy photograph of (a) FV (1:1), (b) FVI (1:1).
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dispersion, microsphere, tablet and pure drug was studied using
EC and HPMC as polymers for the formulations. Dissolution
profiles of pure drug and different dosage form of solid dis-
persion, microsphere and tablet after 110 min is shown in Fig. 6.
It revealed that all formulations underwent an initial
linear release phase followed by equilibration. In addition, it
can be clearly observed that the dissolution rate of pure
drug was low because 53.4% of drug dissolved in 110 min and
there was no change observed in its solubility and drug release
when increasing time which revealed its intrinsic solubility
property.
In the case of other formulations, there was a marked in-
crease in the dissolution rate of HCT, when compared to pure
HCT which exhibited that molecular dispersion and size re-
duction of coarse particle into colloidal particle increase the
surface area and wettability, thereby increasing drug release.
The dissolution rate of drug after 110 min for formulation T,
FI, FII, FIII, FIV, FV and FVI was found to be 62.77%, 99.03%,
83.37%, 80.59%, 97.62%, 72.25% and 76.52% respectively. The
decrease in drug release in the tablet when compared
to formulation FI, FII, FIII, FIV, FV and FVI may be due to no
reduction in particle size by their preparation technique and
added excipients didn’t have much influence in their
solubility which showed the relatively same release profile of
pure drug. But the slight increase in drug release in tablet
than the pure drug may be due to the addition of a wetting
agent such as sodium lauryl sulfate, sodium di-isobutyl
sulfosuccinate.
In the case of FI and FII, the rapid release of the drug was
shown in FI and controlled release was shown in FII.The results
revealed that the release rate decreased as the concentration
of HPMC increased. At higher polymer loading, the viscosity
of the gel matrix is increased which results in a decrease in
the effective diffusion coefficient of the drug [27]. This indi-
cates that the drug/polymer ratio is an important factor
affecting the rate of release of drugs from HPMC matrices.
Factors that may contribute to differences in drug dissolu-
tion profile as a function of changes in the total polymer
Fig. 5 – Optical microscopy photograph of (a) pure drug, (b) FI, (c) FII, (d) FIII, (e) FIV.
Fig. 6 – Comparative dissolution profiles of HCT solid dispersion (formulation I, II, III, IV), microsphere (V, VI), tablet (T) and
pure drug (D).
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concentration include differences in water penetration rate,
water absorption capacity and polymer swelling [15].
Moreover, this may be due to increase in viscosity which will
increase the particle size and decrease the surface area. In-
crease in viscosity may also increase the diffusional path length,
which might also be the reason for reduction in drug release.
In contrast, in the case of FIII and FIV, the increase in drug
release was shown in FIV which may attribute to increased pen-
etration of the solvent molecules in the presence of the
hydrophobic polymer, leading to increased diffusion of the drug
from the matrix, showing a complete polymer saturation
solution.
In the case of FV and FVI, the increased and controlled
release was observed in FVI which may be due to the pres-
ence of suitability of carrier (EC, PVA) and the percentage of
PVA which may prevent aggregation of fine drug particles,
thereby providing a larger surface area for dissolution. The
wetting properties are also greatly increased due to the sur-
factant property of the polymer (PVA), resulting in decreased
interfacial tension between the medium and the drug, hence
the higher dissolution rates. The presence of PVA polymers
also inhibits crystal growth of the drug which facilitates faster
dissolution. From the SEM image result, it was evident that
the addition of PVA is a suitable stabilizer to prevent aggre-
gation and keep the product uniform in size and shape in
FVI, thereby providing a larger surface area for dissolution.
But in the case of FV, the concentration of polymer (HPMC)
and the percentage of PVA are not suitable for controlling the
release of the drug and the SEM image itself shows irregular
shape and size which may affect the viscosity, thereby retard-
ing drug release. From this release study, it was evident that
the PVA stabilizer even possesses good inherent properties,
when combined with two different natures of polymer (HPMC
– natural polymer, EC – semi synthetic polymer) in microsphere
preparation which alters drug release. In addition, due to the
high viscous nature of HPMC polymer than EC polymer,
it increases the diffusion path length, which might also be
the reason for reduction in drug release. Hence FV showed
controlled low percentage of drug release and FVI showed con-
trolled high percentage of drug release. Besides, it can be clearly
observed that the dissolution/release rate of drug was higher
in all the solid dispersion formulations (FI, FII, FIII, FIV was
99.03%, 83.37%, 80.59% and 97.62% respectively) than
microsphere formulations (FV, FVI was 72.25% and 76.52%
respectively).
Solid dispersions and microspheres were highly in amor-
phous form (Figs. 3–5), in contrast to pure HCT, which
contributed to an increase of dissolution/release of drug in a
prolonged and controlled manner, not in the immediate
manner. Prolonged and controlled release of HCT was achieved
with the preparation of solid dispersions and microsphere using
a solvent evaporation method in the FII, FIII, FV, and FVI at
the 20 min onwards, which may be due to using of second
generation polymer (EC and HPMC), but which cannot be seen
using first generation polymer where rapid release of the drug
occurs when increasing time. Besides, the immediate and pro-
longed release profiles of solid dispersions can be attributed
to the dispersion of drug in the polymer matrices of FI and
FIV which may be due to increased wettability, improved
dispersibility of drug particles, and existence of the drug in
amorphous form with improved solubility and absence of ag-
gregation of drug particles. But in the case of FV and FVI, the
second generation polymer was actively involved in the con-
trolled release of drug from the microsphere which may be
due to the presence of the drug as core within the rate con-
trolling polymer (reservoir type), wherein the solid dispersion
drug is homogeneously dispersed in the rate controlling polymer
(monolithic).
Kim et al. and Vilhelmsen et al. reported that the
second generation solid dispersions were made using
amorphous carriers, which are mostly polymers [4,28], whereas
the first generation solid dispersions were made using crys-
talline carriers.These form thermodynamically stable crystalline
solid dispersions [16]. In the 1960s, it was reported that
amorphous solid dispersions were more effective than crys-
talline solid dispersions due to their thermodynamic stability
[29,30]. Also Lloyd et al. and Pokharkar et al. demonstrated
that drugs with low water solubility have higher solubility when
they are in amorphous state rather than in crystalline state
[31,32]. Theoretically, a certain amount of energy is de-
manded for breaking up the crystal lattice during the dissolution
process if the drug is in its crystal state [4]. However, amor-
phous drugs do not need such energy [33], making the drug
more easily released [34]. This improved drug release rate ul-
timately promotes drug’s bioavailability, making solid
dispersions more ideal for administrating hydrophobic oral
drugs [4].
From the result, it was evident that using second genera-
tion polymer and its different percentage of concentration in
solid dispersion is an advanced approach for immediate and
prolonged release of poorly soluble drug than by using first
generation polymer in solid dispersion which has immediate
release. Moreover, in optimized condition/using third genera-
tion polymer (which include additional surface active properties
e.g. inulin, inutec SP1, compritol 888 ATO, gelucire 44/14,
poloxamer 407, etc.,) in the preparation of solid dispersion
may be an advance technology for controlled release of poorly
soluble drug than microsphere. Also, due to its easy prepara-
tion, solid dispersion would be one of the exciting frontiers
of controlled release drug delivery systems [18,35]. Kim et al.
reported some commercial applications of solid dispersion for-
mulation using second generation polymer which is shown
in Table 2 [4].
4. Conclusion
The present study was conducted to improve and compare the
dissolution of HCT using two different types of formulations
(solid dispersions and microspheres) by a solvent evapora-
tion method with different ratios of HPMC and EC. From the
result, it was clear and evident that even the solid dispersion
(SD) technique and microsphere (MS) technique had im-
proved the dissolution rate of drug to a great extent, the
percentage of the dissolution/release rate was higher in solid
dispersion formulation than microsphere formulation. Finally,
it could be concluded that with future development of this tech-
nology, the solid dispersions have tremendous potential in the
area of controlled release dosage form design such as
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microspheres because of the wide availability of a variety of
carriers and it would continue to enable novel applications in
drug delivery and solve problems associated with the deliv-
ery of poorly soluble drugs.
R E F E R E N C E S
[1] Lipinski CA, Lombardo F, Dominy BW, et al. Experimental
and computational approaches to estimate solubility and
permeability in drug discovery and development settings.
Adv Drug Deliv Rev 2001;46:3–26.
[2] Mahesh I Limbachiya NT. Techniques solubility
enhancement poorly soluble drugs: a review. IJPRD
2012;4(04):71–86.
[3] Nora AU, Bernhard CL. Solid dispersions of nimodipine and
polyethylene glycol 2000: dissolution properties and
physico-chemical characterization. Eur J Pharm Biopharm
2005;59:107–118.
[4] Kim KT, Lee JY, Lee MY, et al. Solid dispersions as a drug
delivery system. J Pharm Investig 2011;41(3):125–142.
[5] Lackman L. Teoria e pratica na industria farmaceutica.
1st ed. Lisboa: Fundaçao Calouste Gulbenkian; 2001. p. 737–
738.
[6] Tran HTT, Park JB, Hong KH, et al. Preparation and
characterization of pH-independent sustained release tablet
containing solid dispersion granules of a poorly water
soluble drug. Int J Pharm 2011;415(1–2):83–88.
[7] Kim HJ, Lee SH, Lim EA, et al. Formulation optimization of
solid dispersion of mosapride hydrochloride. Arch Pharm
Res 2011;34(9):1467–1475.
[8] Dhanalekshmi UM, Poovi G, Kishore N, et al. In-vitro
characterization and in-vivo toxicity study of repaglinide
loaded poly (methyl methacrylate) nanoparticles. Int J
Pharm 2010;396:194–203.
[9] Vasconcelos T. Solid dispersions as strategy to improve oral
bioavailability of poor water soluble drugs. Drug Discov
Today 2007;12:23–25.
[10] Dhanalekshmi UM, Poovi G, Reddy NP. In-vitro observation of
repaglinide engineered polymeric nanoparticles. Dig J
Nanomater Bios 2012;7(1):1–18.
[11] Poovi G, Dhanalekshmi UM, Narayanan N, et al. Preparation
and characterization of repaglinide loaded chitosan
polymeric nanoparticles. Res J Nanosci Nanotechnol
2011;1(1):12–24.
[12] Giri TK, Kumar K, Alexander A, et al. A novel and alternative
approach to controlled release drug delivery system based
on solid dispersion technique. Bull Fac Pharm Cairo Univ
2012;50:147–159.
[13] Patel RB, Patel UR, Rogge MC, et al. Bioavailability of
hydrochlorothiazide from tablets and suspensions. J Pharm
Sci 1984;73:35–361.
[14] Sietsema WK. The absolute oral bioavailability of selected
drugs. Int J Clin Pharmcol Ther Toxicol 1989;27:179–211.
[15] Wan LS, Heng PW, Wong LF. Relationship between swelling
and drug release in a hydrophilic matrix. Drug Dev Ind
Pharm 1993;19:1201–1210.
[16] Nighute AB, Bhise SB. Preparation and evaluation of
rifabutin loaded polymeric microspheres. Res J Pharm
Technol 2009;2(2):371–374.
[17] Konno H, Handa T, Alonzo DE, et al. Effect of polymer type
on the dissolution profile of amorphous solid dispersion
containing felodipine. Eur J Pharm Biopharm 2008;70:493–
499.
[18] Vasconcelos TF, Sarmento B, Costa P. Solid dispersions as
strategy to improve oral bioavailability of poor water soluble
drugs. Drug Discov Today 2007;12:1068–1075.
[19] Menon D, El-Ries M, Alexander KS, et al. A thermal analysis
study of the decomposition of hydrochlorothiazide. Instrum
Sci Technol 2002;30:329–340.
[20] Dhanaraju MD, Elizabeth S, Poovi G. Dexamethasone release
from glutaraldehyde cross-linking chitosan microspheres: in
vitro/in vivo studies and non-clinical parameters response in
rat arthritic model. J Pharm Investig 2011;41(5):279–288.
[21] Blanco MD, Gomez C, Olmo R, et al. Chitosan microspheres
in PLG films as devices for cytarabine release. Int J Pharm
2000;202:29–39.
[22] Jagtap YM, Bhujbal RK, Ranade AN, et al. Effect of various
polymers concentrations on physicochemical properties
of floating microspheres. Indian J Pharm Sci 2012;74(6):512–
520.
[23] Phutane P, Shidhaye S, Lotlikar V, et al. In vitro evaluation of
novel sustained release microspheres of glipizide prepared
by the emulsion solvent diffusion-evaporation method.
J Young Pharm 2010;2(1):35–41.
[24] British Pharmacopoeia Commission. British Pharmacopoeia,
vol. 1. London: 2003. p. 874–875.
[25] Chiou W, Riegelman S. Pharmaceutical applications of
solid dispersion systems. Pharm Acta Helv 1971;60:1281–
1301.
[26] Jain SK, Awasthi AM, Jain NK, et al. Calcium silicate based
microspheres of repaglinide for gastroretentive floating drug
delivery: preparation and in vitro characterization. J Control
Release 2005;107:300–309.
[27] Skoug JW, Mikelsons MV, Vigneron CN, et al. Qualitative
evaluation of the mechanism of release of matrix sustained
release dosage forms by measurement of polymer release. J
Control Release 1993;27:227–245.
[28] Vilhelmsen T, Eliasen H, Schaefer T. Effect of a melt
agglomeration process on agglomerates containing solid
dispersions. Int J Pharm 2005;303:132–142.
[29] Chiou WL, Riegelman S. Pharmaceutical applications of solid
dispersion systems. J Pharm Sci 1971;60:1281–1302.
[30] Simonelli AP, Mehta SC, Higuchi WI. Dissolution rates of
high energy polyvinylpyrrolidone (PVP)-sulfathiazole
coprecipitates. J Pharm Sci 1969;58:538–549.
[31] Lloyd GR, Craig DQ, Smith A. A calorimetric investigation
into the interaction between paracetamol and polyethylene
glycol 4000 in physical mixes and solid dispersions. Eur J
Pharm Biopharm 1999;48:59–65.
Table 2 – Examples of commercial applications of solid dispersion formulation.
Trade name Drug company Ingredient in solid dispersion Efficacy
Hepcure CJ Jeil-Jedang Amorphous adefovir dipivoxil in solid dispersion Hepatitis type B
Sporanox Janssen/Johnson & Johnson Itraconazole in HPMC and PEG 20000 Antifungal
Cesamet Lilly Nabilone in PVP CINV
(Chemotherapy induced
nausea and vomiting)
440 a s i an j o u rna l o f p h a rma c eu t i c a l s c i e n c e s 1 0 ( 2 0 1 5 ) 4 3 3 – 4 4 1
[32] Pokharkar VB, Mandpe LP, Padamwar MN, et al.
Development, characterization and stabilization of
amorphous form of a low T-g drug. Powder Technol
2006;167:20–25.
[33] Ghaste R, Chougule DD, Shah RR, et al. Solid dispersions: an
overview. Pharm Rev 2009;7.
[34] Taylor LS, Zografi G. Spectroscopic characterization of
interactions between PVP and indomethacin in amorphous
molecular dispersions. Pharm Res 1997;14:1691–
1698.
[35] Pouton CW. Formulation of poorly water-soluble drugs for
oral administration: physicochemical and physiological
issues and the lipid formulation classification system. Eur J
Pharm Sci 2006;29:278–287.
441a s i an j o u rna l o f p h a rma c eu t i c a l s c i e n c e s 1 0 ( 2 0 1 5 ) 4 3 3 – 4 4 1
